protein S

Protein S is synthesized primarily in the liver (and to a lesser extent endothelial cells and megakaryocytes) as a vitamin K-dependent protein, similar to factors II, VII, IX, X, and Protein C. Unlike Protein C, Protein S itself has no direct enzymatic activity; rather it serves as a non-enzymatic cofactor that binds to activated Protein C (APC) on phospholipid membrane surfaces, dramatically increasing APC's proteolytic efficiency in inactivating factors Va and VIIIa, thereby downregulating thrombin generation.

In plasma, about 60% of Protein S is bound to C4b-binding protein (C4BP), a complement regulatory protein, rendering it functionally inactive; only the free (unbound) ~40% fraction has anticoagulant cofactor activity. Inflammatory states (e.g., sepsis, acute phase reactions) increase C4BP levels, reducing free Protein S and promoting a transient procoagulant state.

Clinical significance: Hereditary Protein S deficiency (autosomal dominant) predisposes to recurrent venous thromboembolism (DVT, PE), especially in young patients, and can cause warfarin-induced skin necrosis when anticoagulation is initiated without bridging heparin (due to the rapid drop in protein C/S relative to procoagulant factors). Acquired deficiency occurs in liver disease, DIC, nephrotic syndrome (urinary loss), pregnancy, oral contraceptive use, and vitamin K antagonist therapy (e.g., warfarin, which inhibits synthesis of all vitamin K-dependent factors including Protein S and Protein C).

Laboratory workup includes measuring free Protein S antigen levels and functional activity assays; testing should be deferred during acute thrombosis or anticoagulant therapy, as these can falsely lower levels. Protein S deficiency is a classic board topic frequently tested alongside Protein C deficiency and Factor V Leiden (APC resistance) in the differential diagnosis of inherited thrombophilia.